Cendakimab

• Target :

  Interleukin

• Related Pathways :

  Immunology/Inflammation

• Purity :

  0.96

• Bioactivity :

  Cendakimab (RPC4046) is a humanized monoclonal antibody targeting IL-13. It selectively targets the IL-13 receptor (IL13R-?1 and IL13R-?2), used in research on atopic dermatitis.

• Shipping Conditions :

  Cool pack

• Storage Temperature :

  -20°C

• CAS Number :

  2151032-62-9